- Home
- GCTS vs RPTX Comparison
GCTS vs RPTX Comparison
Compare GCTS & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTS
- RPTX
- Stock Information
- Founded
- GCTS 1998
- RPTX 2016
- Country
- GCTS United States
- RPTX Canada
- Employees
- GCTS N/A
- RPTX N/A
- Industry
- GCTS Blank Checks
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- GCTS Finance
- RPTX Health Care
- Exchange
- GCTS Nasdaq
- RPTX Nasdaq
- Market Cap
- GCTS 59.1M
- RPTX 63.9M
- IPO Year
- GCTS N/A
- RPTX 2020
- Fundamental
- Price
- GCTS $1.48
- RPTX $1.41
- Analyst Decision
- GCTS Strong Buy
- RPTX Strong Buy
- Analyst Count
- GCTS 1
- RPTX 3
- Target Price
- GCTS $5.00
- RPTX $4.50
- AVG Volume (30 Days)
- GCTS 1.1M
- RPTX 94.4K
- Earning Date
- GCTS 08-13-2025
- RPTX 08-05-2025
- Dividend Yield
- GCTS N/A
- RPTX N/A
- EPS Growth
- GCTS N/A
- RPTX N/A
- EPS
- GCTS N/A
- RPTX N/A
- Revenue
- GCTS $6,359,000.00
- RPTX $1,073,000.00
- Revenue This Year
- GCTS $133.55
- RPTX N/A
- Revenue Next Year
- GCTS $347.37
- RPTX N/A
- P/E Ratio
- GCTS N/A
- RPTX N/A
- Revenue Growth
- GCTS N/A
- RPTX N/A
- 52 Week Low
- GCTS $0.90
- RPTX $0.89
- 52 Week High
- GCTS $5.65
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- GCTS 60.22
- RPTX 51.83
- Support Level
- GCTS $1.35
- RPTX $1.33
- Resistance Level
- GCTS $1.53
- RPTX $1.48
- Average True Range (ATR)
- GCTS 0.14
- RPTX 0.05
- MACD
- GCTS 0.05
- RPTX -0.01
- Stochastic Oscillator
- GCTS 92.06
- RPTX 34.37
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.